This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
TheStreet) -- Congratulations to the 11 perfect winners of
TheStreet'sSummer FDA Drug Approval Contest.
"Perfect" because each of the winning contestants went 5-0 in predicting correctly the outcome of the following FDA-related events:
Onyx Pharmaceuticals(ONXX): FDA advisory panel for the cancer drug carfilzomib on June 20.
Arena Pharmaceuticals(ARNA - Get Report): FDA approval decision for the weight-loss drug lorcaserin on June 27.
Vivus(VVUS - Get Report): FDA approval decision for the weight-loss drug Qnexa on July 20.
Amarin(AMRN): FDA approval decision for the prescription fish-oil pill AMR101 on July 26.
Onyx: FDA approval decision for carfilzomib on July 27.
The 11 winners emerged from a record crowd of 134 entries. [You can read more about the <a href="http://www.thestreet.com/story/11584117/1/vivus-arena-obesity-drugs-will-be-approved-investors-say.html">overall predictions from the contest here</a>.]
As you read your name, please take a bow and accept my hearty congratulations:
That's only 10 names. Who was winner No. 11?
Me! Yes, it's true, I actually won my own contest -- without cheating.
Thanks again for participating.
--Written by Adam Feuerstein in Boston.
>To contact the writer of this article, click here:
>To follow the writer on Twitter, go to
>To submit a news tip, send an email to:
Twitter and become a fan on